We are live on ! Find out more
First Manhattan

First Manhattan Portfolio holdings

AUM $36.1B
1-Year Est. Return 11.5%
This Fund
S&P 500
This Quarter Est. Return
-3.36%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$23.6B
AUM Growth
-$1.2B
Cap. Flow
-$152M
Cap. Flow %
-0.64%
Top 10 Hldgs %
59.63%
Holding
1,742
New
84
Increased
209
Reduced
452
Closed
104

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$117M
2
ENTG icon
Entegris
ENTG
+$107M
3
TFX icon
Teleflex
TFX
+$26.6M
4
NKE icon
Nike
NKE
+$25.8M
5
SPGI icon
S&P Global
SPGI
+$20.9M

Sector Composition

Rank Sector Weight
1 Financials 43.69%
2 Technology 15.09%
3 Healthcare 11.64%
4 Consumer Discretionary 8.73%
5 Communication Services 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQRXW
1676
DELISTED
EQRx, Inc. Warrant
EQRXW
$0 ﹤0.01%
100
WE
1677
DELISTED
WeWork Inc.
WE
$0 ﹤0.01%
2
BOAC
1678
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
-10,450
Closed -$103K
RAD
1679
DELISTED
Rite Aid Corporation
RAD
$0 ﹤0.01%
37
FATH
1680
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$0 ﹤0.01%
22
FATH.WS
1681
DELISTED
Fathom Digital Manufacturing Corporation Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50 per share
FATH.WS
$0 ﹤0.01%
110
HARP
1682
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$0 ﹤0.01%
7
ARNC
1683
DELISTED
Arconic Corporation
ARNC
$0 ﹤0.01%
33
AMRS
1684
DELISTED
Amyris Inc.
AMRS
$0 ﹤0.01%
100
DICE
1685
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
-155,904
Closed -$2.42M
CPUH.WS
1686
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$0 ﹤0.01%
110
WLMS
1687
DELISTED
Williams Industrial Services Group Inc.
WLMS
$0 ﹤0.01%
444
MTVC.WS
1688
DELISTED
Motive Capital Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
MTVC.WS
$0 ﹤0.01%
100
ACOR
1689
DELISTED
Acorda Therapeutics
ACOR
$0 ﹤0.01%
3
AUD
1690
DELISTED
Audacy, Inc.
AUD
$0 ﹤0.01%
232
ML
1691
DELISTED
MoneyLion Inc.
ML
$0 ﹤0.01%
33
-1,334
-98% -$61.2K
LYLT
1692
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$0 ﹤0.01%
11
TMDI
1693
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
-6,600
Closed -$3K
CYRN
1694
DELISTED
CYREN Ltd.
CYRN
$0 ﹤0.01%
5
SRNE
1695
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$0 ﹤0.01%
500
VLDR
1696
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$0 ﹤0.01%
400
-200
-33% -$234
ASAP
1697
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$0 ﹤0.01%
50
PFHD
1698
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
-20,000
Closed -$401K
SVFAW
1699
DELISTED
SVF Investment Corp. Warrant
SVFAW
$0 ﹤0.01%
100
EPHYW
1700
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
$0 ﹤0.01%
200

Similar funds

First Manhattan's Q3 2022 Portfolio in Review

As of Q3 2022, First Manhattan held 1,742 positions worth $23.6B, down 4.8% from $24.8B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

First Manhattan's Q3 2022 filing shows 84 new, 209 increased, 452 reduced and 104 closed positions. Its largest new stake was Element Solutions: 151,800 shares worth $2.47M. The largest sale was Apple, an estimated $59.9M.

By sector, the portfolio is most concentrated in Financials at 44% of assets, up from 43% a quarter earlier, followed by Technology and Healthcare.

  • First Manhattan's largest Q3 2022 buy was Element Solutions: 151,800 shares worth $2.47M.
  • First Manhattan added most to Linde in Q3 2022, an estimated $117M increase.
  • First Manhattan's biggest Q3 2022 reduction was Apple, cutting an estimated $59.9M.
  • First Manhattan fully exited Blueprint Medicines in Q3 2022, selling an estimated $29.7M.
  • First Manhattan's ten largest holdings make up 60% of its $23.6B portfolio in Q3 2022.
  • First Manhattan opened 84 new positions and closed 104 in Q3 2022.
  • First Manhattan's portfolio value fell 4.8% quarter-over-quarter to $23.6B.

Based on First Manhattan's 13F filing for Q3 2022, filed 14 Nov 2022.